EMAIL THIS PAGE TO A FRIEND

Journal of immunology (Baltimore, Md. : 1950)

GM-CSF but not IL-17 is critical for the development of severe interstitial lung disease in SKG mice.


PMID 24951817

Abstract

Interstitial lung disease (ILD) is a common complication and sometimes a prognostic factor of connective tissue diseases (CTDs) in humans. However, suitable animal model of severe CTD-associated ILD (CTD-ILD) has been limited. In this study, we showed that zymosan-treated SKG mice developed not only arthritis but also chronic-progressive ILD with high mortality over several months. The pathological and clinical features of ILD in zymosan-treated SKG mice were similar to that of human severe CTD-ILD. ILD in this mouse was characterized by massive infiltration of Th17 cells, GM-CSF-producing CD4(+) T cells, and CD11b(+) Gr1(+) neutrophils with fibrosis. Naive SKG T cells were skewed to differentiate into GM-CSF-producing cells, and GM-CSF secreted by T cells enhanced IL-6 and IL-1β production by macrophages, which in turn enhanced differentiation of IL-17A- and/or GM-CSF-producing T cells and infiltration of neutrophils into lung. Neutralization of GM-CSF completely blocked the development of this ILD, and the blocking of IL-6 signaling resulted in partial prevention of it, whereas neutralization of IL-17A did not. In contrast, the progression of arthritis was inhibited by the neutralization of GM-CSF and slightly by the neutralization of IL-17A, but not by the blocking of IL-6 signaling. These data suggested zymosan-treated SKG mice could be a useful mouse model of severe CTD-ILD, and GM-CSF, rather than IL-17A or IL-6, contributed to the development of ILD in zymosan-treated SKG mice, indicating that neutralization of GM-CSF would be a useful therapeutic strategy for severe CTD-ILD.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB2501381
Anti-Cd28 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2501674
Anti-CD28 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1405583
Anti-CD28 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB1412683
ANTI-IFNA1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB1410692
Anti-IFNA1 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
AV54329
Anti-IL4 antibody produced in rabbit, affinity isolated antibody
SAB2103750
Anti-IL4 antibody produced in rabbit, affinity isolated antibody
I7776 Anti-Interleukin-4 antibody produced in goat, affinity isolated antibody, lyophilized powder
I7526 Anti-Interleukin-4 antibody produced in goat, affinity isolated antibody, lyophilized powder
I8784 Anti-Interleukin-4 antibody produced in goat, IgG fraction of antiserum, lyophilized powder
RAB0100
Human Granulocye-Macrophage Colony Stimulating Factor / CSF2 ELISA Kit, for serum, plasma, cell culture supernatant and urine
SAB4700739 Monoclonal Anti-CD28 antibody produced in mouse, clone JJ319, purified immunoglobulin, buffered aqueous solution
SAB4700751
Monoclonal Anti-CD28 antibody produced in mouse, clone CD28.2, purified immunoglobulin, buffered aqueous solution
WH0003439M7
Monoclonal Anti-IFNA1 antibody produced in mouse, clone 3C6, purified immunoglobulin, buffered aqueous solution
SAB4700340 Monoclonal Anti-IFNG antibody produced in mouse, clone G-23, purified immunoglobulin, buffered aqueous solution
I7034 Monoclonal Anti-Interleukin-4 antibody produced in mouse, clone 3007, purified immunoglobulin, lyophilized powder
I7159 Monoclonal Anti-Interleukin-4 antibody produced in mouse, clone 3010, purified immunoglobulin, lyophilized powder
SAB4700622 Monoclonal Anti-Ly6g-FITC antibody produced in rat, clone RB6-8C5, purified immunoglobulin, buffered aqueous solution